Multislice Computed Tomography Angiography for Noninvasive Assessment of the 18-Month Performance of a Novel Radiolucent Bioresorbable Vascular Scaffolding Device
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“For decades, new percutaneous coronary therapies have required invasive angiography to assess late lumen loss. Considering the good diagnostic accuracy of [coronary CTA] in the absence of metal stents, and advantages in safety, [this technology] offers a noninvasive alternative to catheterization both for clinical care as well as research.”
RSRobert S. SchwartzCardiologist, Minneapolis Heart Institute Foundation
“way too high”
DEDavid E. KandzariInterventional cardiologist, Piedmont Heart Institute, Atlanta
“I don't think there's any remarkable theme with these [imaging] metrics.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Nieman et al. (2013) studied this question.